Daily News Podcast

Alarming rate of diabetes medication discontinuations


 

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months. Also today, the FDA approves Ajovy for migraine prevention, some teens are using cannabis in their vapor devices, and alpha-blocker use is still common and still risky.


Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Is it time for PCPs to take over chronic HCV?
MDedge Rheumatology
Rivaroxaban data abound at ESC 2018
MDedge Rheumatology
New MI definition for infarction vs injury
MDedge Rheumatology
Lorcaserin shows cardiovascular safety
MDedge Rheumatology
Lung function decline linked to cardiovascular risk
MDedge Rheumatology
Modest alcohol and NAFLD
MDedge Rheumatology
Cardiovascular risk with diclofenac
MDedge Rheumatology
Baloxavir, oseltamivir similar for influenza
MDedge Rheumatology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Rheumatology
Urine drug screens show improper medication use
MDedge Rheumatology